Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary

Sonnet Biotherapeutics Holdings

20/12/2021 14:31

* Sonnet Biotherapeutics Holdings Inc  SONN.OQ  reported a
quarterly adjusted loss of 17 cents​​ per share for the quarter
ended in September. The mean expectation of two analysts for the
quarter was for a loss of 22 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Sonnet Biotherapeutics Holdings Inc's reported EPS for the
quarter was a loss of 17 cents​.
* The mean earnings estimate of analysts had fallen by
about 37.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sonnet Biotherapeutics Holdings Inc shares had fallen by 22.4%
this quarter and lost 78.9% so far this year.
* The company reported a quarterly loss of $6.95 million.
* Wall Street's median 12-month price target for Sonnet
Biotherapeutics Holdings Inc is $2.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated December 20 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated